You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dyskinesia, Drug-Induced

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease

Recruiting
  • Parkinson Disease
  • Dyskinesia, Drug-Induced
  • Intravenous Infusion
  • Portland, Oregon
  • +2 more
Dec 23, 2022

Parkinson Disease, Dyskinesia, Medication-Induced Trial in Lublin, Warszawa, Oswiecim (CPL500036 - low dose, CPL500036 - high

Recruiting
  • Parkinson Disease
  • Dyskinesia, Medication-Induced
  • CPL500036 - low dose
  • +2 more
  • Lublin, Lubelskie, Poland
  • +3 more
May 9, 2022

Parkinson Disease, Dyskinesia, Drug-Induced, Dyskinesias Trial in United States (Dipraglurant)

Recruiting
  • Parkinson Disease
  • +2 more
  • Augusta, Georgia
  • +6 more
Apr 18, 2022

Medication-Induced Dyskinesia Trial in Sweden (NLX-112, Placebo)

Recruiting
  • Medication-Induced Dyskinesia
  • Gothenburg, Sweden
  • +4 more
Nov 24, 2021

Parkinson Disease, Dyskinesia, Medication-Induced, L-Dopa Causing Adverse Effects in Therapeutic Use Trial (AV-101, Placebo)

Not yet recruiting
  • Parkinson Disease
  • +2 more
  • (no location specified)
May 25, 2021

Drug-induced Tardive Dyskinesia Trial in Los Angeles (SNC-102, Placebo)

Withdrawn
  • Drug-induced Tardive Dyskinesia
  • Los Angeles, California
    UCLA - Greater Los Angeles
Apr 8, 2021

Parkinson Disease, Dyskinesia, Drug-Induced, Dyskinesias Trial in United States (Dipraglurant, Placebo)

Recruiting
  • Parkinson Disease
  • +2 more
  • Phoenix, Arizona
  • +40 more
May 18, 2022

Levodopa-Induced Dyskinesia, Parkinson's Disease Trial in Tucson (Intervention: Ketamine)

Active, not recruiting
  • Levodopa-Induced Dyskinesia
  • Parkinson's Disease
  • Intervention: Ketamine
  • Tucson, Arizona
    Scott J Sherman
Aug 27, 2023

Dyskinesia, Drug-Induced, Parkinson Disease Trial (Safinamide Methanesulfonate 150mg, Safinamide Methanesulfonate 100mg,

Withdrawn
  • Dyskinesia, Drug-Induced
  • Parkinson Disease
  • Safinamide Methanesulfonate 150mg
  • +2 more
  • (no location specified)
Jun 15, 2020

Levodopa-induced Dyskinesia, Parkinson's Disease Trial in Bunkyo (DSP-9632P 27.5 mg, DSP-9632P 82.5 mg, Placebo)

Recruiting
  • Levodopa-induced Dyskinesia
  • Parkinson's Disease
  • DSP-9632P 27.5 mg
  • +4 more
  • Bunkyo, Tokyo, Japan
    Nippon Medical School Hospital
Jun 23, 2022

Parkinson Disease, Dyskinesia, Drug-Induced, Levodopa Trial in Worldwide (AFQ056)

Completed
  • Parkinson Disease
  • +2 more
  • Sunnyvale, California
  • +21 more
Dec 15, 2020

Parkinson Disease Trial in France (Amantadine, )

Completed
  • Parkinson Disease
  • Aix en Provence, France
  • +17 more
Feb 2, 2021

Dyskinesias, Movement Disorders, CNS Diseases Trial in United States (Ketamine, Midazolam)

Active, not recruiting
  • Dyskinesias
  • +4 more
  • Tucson, Arizona
  • +6 more
Feb 16, 2022

Drug-Induced Acute Liver Injury Trial in Tianjin (Bicyclol tablets)

Recruiting
  • Drug-Induced Acute Liver Injury
  • Bicyclol tablets
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Feb 2, 2023

Tuberculosis, Drug Induced Liver Injury, Hepatitis Trial in Bangkok (N acetyl cysteine)

Recruiting
  • Tuberculosis
  • +2 more
  • N acetyl cysteine
  • Bangkok, Thailand
    Faculty of Medicine, Siriraj Hospital
Feb 12, 2023

Oncology Trial in Huy (Sedakit (R) using hypnosis induced by the virtual reality device, drug intervention)

Completed
  • Oncology
  • Sedakit (R) using hypnosis induced by the virtual reality device
  • drug intervention
  • Huy, Belgium
    CHR de Huy
Apr 3, 2023

Drug-Induced Movement Disorder Trial in Burlington (Telemedicine Consult, In-person Consult)

Recruiting
  • Drug-Induced Movement Disorder
  • Telemedicine Consult
  • In-person Consult
  • Burlington, Vermont
    University of Vermont Medical Center
Sep 23, 2023

Remaxol® in Drug-induced Liver Injuries During Antitumor Therapy

Recruiting
  • Cancer
  • Drug Induced Liver Injury
  • Krasnoyarsk, Russian Federation
  • +4 more
Mar 16, 2023

Drug-Induced Nephropathy Trial in Cairo (N Acetylcysteine)

Recruiting
  • Drug-Induced Nephropathy
  • N Acetylcysteine
  • Cairo, Egypt
    Helwan University
Nov 7, 2023

Drug-Induced Liver Injury, Cholestatic Liver Injury, Mixed Liver Injury Trial in Shanghai (MT2004 Capsule, MT2004 Capsule

Recruiting
  • Drug-Induced Liver Injury
  • +2 more
  • MT2004 Capsule
  • MT2004 Capsule Placebo
  • Shanghai, Shanghai, China
    Shanghai Jiaotong University School of Medicine,Renji Hospital
Aug 25, 2023

Drug Toxicity Trial in Rawalpindi (N-Acetylcysteine, Chemotherapy)

Active, not recruiting
  • Drug Toxicity
  • Rawalpindi, Punjab, Pakistan
    Medical Oncology department, Fauji Foundation Hospital
Aug 25, 2023

Drug-induced Liver Injury Trial in Beijing

Recruiting
  • Drug-induced Liver Injury
    • Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Aug 27, 2022

    Osteoarthritis Trial (Probiotics capsule, Placebo capsule)

    Not yet recruiting
    • Osteoarthritis
    • Probiotics capsule
    • Placebo capsule
    • (no location specified)
    Aug 11, 2023

    Microstomia, Scleroderma Trial (Hyaluronidase, co2 laser)

    Not yet recruiting
    • Microstomia
    • Scleroderma
    • (no location specified)
    Aug 16, 2023

    Drug Induced Neuropathy in Children With ALL

    Recruiting
    • Acute Lymphocytic Leukemia
      • Trieste, Friuli Venezia Giulia, Italy
        IRCCS materno infantile Burlo Garofolo
      Mar 31, 2023